Nucleolin as a Potent Biomarker for Predicting Tumor Recurrence among Patients with Hepatocellular Carcinoma after Transplantation

Guanrong Chen
The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China

Xin Hu
Zhejiang University School of Medicine, Hangzhou, China

Yingchen Huang
The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China

Huigang Li
Zhejiang University School of Medicine, Hangzhou, China

Libin Dong
Zhejiang University School of Medicine, Hangzhou, China

Yao Jiang
Department of Basic Medicine, Hangzhou Medical College, Hangzhou, China

Di Lu
Department of Hepatobiliary and Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People‘s Hospital (Affiliated People‘s Hospital), Hangzhou Medical College, Zhejiang, China

Feng Jiang
Department of Big Data in Health Science, and Center for Clinical Big Data and Statistics, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Xiuyang Li
Department of Big Data in Health Science, and Center for Clinical Big Data and Statistics, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Beicheng Sun
Department of Hepatobiliary Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China

Shusen Zheng
Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Ren Lang
Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing, China

Xiao Xu
School of Clinical Medicine, Hangzhou Medical College, Hangzhou, China; Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China

Ronggao Chen
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Comments (0)

No login
gif